SCHEMBL20053996

SCHEMBL20053996

CN/C=C(\C=N)Nc1nccc(-c2ccc(CNC(=O)N3CCC(C(C)(C)C)C3)c(Cl)c2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 8/20 0.55
▸ EPHX2 P34913 10/20 0.41
▸ CD69 Q07108 2/20 0.41
▸ JAK2 O60674 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HRH2 P25021 1/20 0.38
▸ CDK7 P50613 1/20 0.38
▸ AAK1 Q2M2I8 1/20 0.38
▸ MAP3K19 Q56UN5 1/20 0.38
▸ CDKL2 Q92772 1/20 0.38
▸ RIOK1 Q9BRS2 1/20 0.38
▸ RIOK2 Q9BVS4 1/20 0.38
▸ BMP2K Q9NSY1 1/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2J2 P51589 2/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ AKT3 Q9Y243 1/20 0.36
▸ JUN P05412 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ MAPK8 P45983 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20053990 0.89 BTK (0.53) BTKEPHX2CD69JAK2CYP3A4
SCHEMBL20054016 0.82 BTK (0.52) BTKCD69JAK2CYP3A4HRH2
SCHEMBL20054045 0.81 AAK1 (0.47) BTKAAK1AKT3
SCHEMBL16794087 0.79 BTK (0.85) BTKCD69JAK2CYP3A4HRH2
SCHEMBL20461147 0.79 BTK (0.49) BTKCD69JAK2CYP3A4HRH2
SCHEMBL20053999 0.79 AKT3 (0.39) BTKAAK1AKT3CDK2
SCHEMBL20053966 0.79 BTK (0.52) BTKCD69JAK2CYP3A4HRH2
SCHEMBL20461100 0.77 BTK (0.47) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16814190 0.76 BTK (0.69) BTKEPHX2CD69JAK2CYP3A4
SCHEMBL16794451 0.74 BTK (0.56) BTKEPHX2CD69JAK2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3357921-A2 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY Sunesis Pharmaceuticals, Inc. (US) 2018-08-08 — — EP disclosed
EP-3080103-B1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY BIOGEN MA INC (US) 2018-04-18 — — EP disclosed
Send feedback